<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Stenting and Aggressive Medical Management for Preventing Recurrent <z:hpo ids='HP_0001297'>Stroke</z:hpo> and Intracranial Stenosis (SAMMPRIS) trial, a randomized clinical trial comparing aggressive medical management to stenting with aggressive medical management for symptomatic intracranial stenosis, was prematurely halted when a high rate of periprocedural events was found in the stent arm </plain></SENT>
<SENT sid="1" pm="."><plain>The trial also demonstrated a high rate of <z:hpo ids='HP_0001297'>stroke</z:hpo> with medical management </plain></SENT>
<SENT sid="2" pm="."><plain>This article explores possible reasons for these outcomes and discusses some weaknesses of the trial </plain></SENT>
<SENT sid="3" pm="."><plain>Against this background endovascular therapy should continue to be explored in the treatment of this disease </plain></SENT>
</text></document>